X marks the shot against malaria

Raphael A. Reyes; Rolando Garza; Evelien M. Bunnik

doi:10.1016/j.immuni.2023.01.018

X marks the shot against malaria

Raphael A. Reyes
, Rolando Garza
, Evelien M. Bunnik

Department of Microbiology, Immunology & Molecular Genetics

Producción científica: Comment/debate › revisión exhaustiva

1 Cita (Scopus)

Resumen

The development of a transmission-blocking vaccine (TBV) against malaria is hampered by poor understanding of functional antibody responses. In this issue of Immunity, Fabra-Garcia et al., Ivanochko et al., and Tang et al. isolate human monoclonal antibodies against the two most promising TBV candidates, Pfs48/45 and Pfs230, and map the epitopes responsible for potent transmission-reducing activity.

Idioma original	English (US)
Páginas (desde-hasta)	234-236
Número de páginas	3
Publicación	Immunity
Volumen	56
N.º	2
DOI	https://doi.org/10.1016/j.immuni.2023.01.018
Estado	Published - feb 14 2023

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Infectious Diseases

Acceder al documento

10.1016/j.immuni.2023.01.018

Otros archivos y enlaces

Citar esto

@article{5f74a72642174f0ab771a3a1ca5b174a,

title = "X marks the shot against malaria",

abstract = "The development of a transmission-blocking vaccine (TBV) against malaria is hampered by poor understanding of functional antibody responses. In this issue of Immunity, Fabra-Garcia et al., Ivanochko et al., and Tang et al. isolate human monoclonal antibodies against the two most promising TBV candidates, Pfs48/45 and Pfs230, and map the epitopes responsible for potent transmission-reducing activity.",

author = "Reyes, \{Raphael A.\} and Rolando Garza and Bunnik, \{Evelien M.\}",

note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Inc.",

year = "2023",

month = feb,

day = "14",

doi = "10.1016/j.immuni.2023.01.018",

language = "English (US)",

volume = "56",

pages = "234--236",

journal = "Immunity",

issn = "1074-7613",

publisher = "Cell Press",

number = "2",

}

TY - JOUR

T1 - X marks the shot against malaria

AU - Reyes, Raphael A.

AU - Garza, Rolando

AU - Bunnik, Evelien M.

PY - 2023/2/14

Y1 - 2023/2/14

N2 - The development of a transmission-blocking vaccine (TBV) against malaria is hampered by poor understanding of functional antibody responses. In this issue of Immunity, Fabra-Garcia et al., Ivanochko et al., and Tang et al. isolate human monoclonal antibodies against the two most promising TBV candidates, Pfs48/45 and Pfs230, and map the epitopes responsible for potent transmission-reducing activity.

AB - The development of a transmission-blocking vaccine (TBV) against malaria is hampered by poor understanding of functional antibody responses. In this issue of Immunity, Fabra-Garcia et al., Ivanochko et al., and Tang et al. isolate human monoclonal antibodies against the two most promising TBV candidates, Pfs48/45 and Pfs230, and map the epitopes responsible for potent transmission-reducing activity.

UR - https://www.scopus.com/pages/publications/85147676339

UR - https://www.scopus.com/pages/publications/85147676339#tab=citedBy

U2 - 10.1016/j.immuni.2023.01.018

DO - 10.1016/j.immuni.2023.01.018

M3 - Comment/debate

C2 - 36792569

AN - SCOPUS:85147676339

SN - 1074-7613

VL - 56

SP - 234

EP - 236

JO - Immunity

JF - Immunity

IS - 2

ER -

X marks the shot against malaria

Resumen

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto